Find in Library
Search millions of books, articles, and more
Indexed Open Access Databases
Calcitriol-Mediated Hypercalcemia, Somatostatin Receptors Expression and 25-Hydroxyvitamin D3-1α- Hydroxylase in GIST Tumors
oleh: Yiraldine Herrera-Martínez, Yiraldine Herrera-Martínez, María José Contreras González, María José Contreras González, Sergio Pedraza-Arévalo, Sergio Pedraza-Arévalo, Maria del Carmen Guerrero Martínez, Maria del Carmen Guerrero Martínez, Ángela Rodrigo Martínez, Ángela Rodrigo Martínez, Alberto González Menchen, Alberto González Menchen, Maria Angeles Blanco Molina, Maria Angeles Blanco Molina, Maria Angeles Gálvez-Moreno, Maria Angeles Gálvez-Moreno, Alberto L. Moreno-Vega, Alberto L. Moreno-Vega, Raúl M. Luque, Raúl M. Luque, Raúl M. Luque, Aura D. Herrera-Martínez, Aura D. Herrera-Martínez
Format: | Article |
---|---|
Diterbitkan: | Frontiers Media S.A. 2022-01-01 |
Deskripsi
Hypercalcemia is a common complication in cancer patients Mainly caused by Parathyroid hormone-related protein (PTHrP) secretion and metastasis. Calcitriol secretion is a rare source of hypercalcemia in solid tumors, especially in gastrointestinal stromal tumors (GIST). We present a case report of a female patient with a 23 cm gastric GIST that expressed somatostatin-receptors and presented with severe hypercalcemia due to calcitriol secretion. Calcium control was achieved with medical treatment before the use of targeted-directed therapies. Surgery was performed and allowed complete tumor resection. Two years later, patient remains free of disease. Molecular analysis revealed the mRNA expression of 25-hydroxyvitamin D3-1-hydroxylase (1αOHase) and vitamin-D receptors in the tumor cells, confirming the calcitriol-mediated mechanism. Furthermore, the expression of the endotoxin recognition factors CD14 and TLR4 suggests an inflammatory mediated mechanism. Finally, the expression of somatostatin-receptors, especially SST2 might have been related with clinical evolution and prognosis in this patient.